Medicine Description ruxotop 15 mg/g
ruxotop 60 gm cream is a medication that contains ruxolitinib, a Janus kinase (JAK) inhibitor. Ruxolitinib inhibits the activity of JAK enzymes, which play a crucial role in the signaling pathways of various cytokines involved in immune responses. By blocking these enzymes, ruxolitinib reduces inflammation and modifies the immune response, thereby helping to manage conditions like vitiligo and atopic dermatitis. This mechanism ultimately leads to a reduction in the symptoms associated with these conditions, facilitating skin repigmentation and inflammation control.
Indications and Uses of ruxotop 60 gm cream
- Vitiligo
- Atopic dermatitis
- Other immune-mediated skin conditions as determined by a healthcare provider
Side Effects of ruxotop 60 gm cream
- Skin irritation at the application site
- Dry skin
- Itching
- Redness
- Increased risk of infections
Storage and Handling
Store ruxotop 60 gm cream at room temperature, away from direct sunlight and moisture. Keep the tube tightly closed when not in use and out of reach of children.
Patient Advice and Precautions
Before using ruxotop cream, consult your healthcare provider about your medical history, especially if you have a history of skin infections. Avoid applying the cream on open wounds or damaged skin. It is essential to monitor for any signs of infection or unusual skin reactions during treatment. Regular follow-ups with your healthcare provider are recommended to assess the effectiveness and safety of therapy.